KYKOF (Kyowa Kirin Co) Total Equity: $5,730 Mil (As of Dec. 2025)


KYKOF Kyowa Kirin Co Ltd KYKOF
82 GF Score
Price $14.43
GF Value $16.79
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Kyowa Kirin Co Total Equity?

Kyowa Kirin Co KYKOF 82 Total Equity is $5,730 Mil as of Dec. 2025. GuruFocus rates KYKOF with a GF Score™ of 82/100 and a GF Value™ of $16.79 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Kyowa Kirin Co's total equity for the quarter that ended in Dec. 2025 was $5,730 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Kyowa Kirin Co Total Equity Historical Data

* Premium members only.

The historical data trend for Kyowa Kirin Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kyowa Kirin Co Total Equity Chart

Kyowa Kirin Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6,475.83 5,654.13 5,809.21 5,531.42 5,729.61

Kyowa Kirin Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5,577.85 5,827.52 5,722.35 5,729.61 5,625.95
KYKOF
82GF Score
Kyowa Kirin Co Ltd KYKOF
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kyowa Kirin Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Kyowa Kirin Co's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=7105.538-1375.929
=5,730

Kyowa Kirin Co's Total Equity for the quarter that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=7105.538-1375.929
=5,730

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $5,730 Mil mean?
Kyowa Kirin Co (KYKOF) has a Total Equity of $5,730 Mil as of Dec. 2025. The total amount of equity as record on a company's balance sheet. View historical data for Kyowa Kirin Co and its competitors.
Is Kyowa Kirin Co's Total Equity too high?
Kyowa Kirin Co's current Total Equity is $5,730 Mil. Overall, Kyowa Kirin Co has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Kyowa Kirin Co's Total Equity compare to ZTS?
Kyowa Kirin Co's Total Equity of $5,730 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Drug Manufacturers company?
A good Total Equity depends on the Drug Manufacturers industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Kyowa Kirin Co and its competitors. Kyowa Kirin Co's current Total Equity is $5,730 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kyowa Kirin Co stock overvalued right now?
Based on GuruFocus' analysis, Kyowa Kirin Co (KYKOF) is currently considered Modestly Undervalued. The stock's GF Value™ is $16.79, compared to a current price of $14.43 — trading 14.1% below its estimated fair value. The current Total Equity is $5,730 Mil. Kyowa Kirin Co's overall GF Score™ is 82/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Kyowa Kirin Co (KYKOF), the current Total Equity is $5,730 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kyowa Kirin Co (KYKOF) Overvalued in 2026?

Based on GuruFocus' analysis, Kyowa Kirin Co stock appears to be undervalued. The current stock price of $14.43 is trading 14.1% below its estimated GF Value™ of $16.79. GuruFocus considers Kyowa Kirin Co to be Modestly Undervalued.

Key valuation signals for KYKOF:

  • Total Equity: $5,730 Mil
  • GF Value™: $16.79 vs. price of $14.43 (14.1% below fair value)
  • GF Score™: 82/100 with 1 warning sign

No single metric tells the full story. See the KYKOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Kyowa Kirin Co Business Description

Address 1-9-2 Otemachi, Chiyoda-ku, Chiyoda-ku, Tokyo, JPN, 100-0004
Kyowa Kirin Co Ltd is engaged in research, development, manufacturing, sales, import and export of prescription pharmaceuticals. Its products include KHK4083/AMG 451, rocatinlimab; ziftomenib; OTL-203 KK8398, infigratinib; KHK4951, tivozanib; OTL-201; KK4277; KK2260; KK2269; KK2845; and KK8123.
82GF Score

Get the complete analysis for KYKOF

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$14.43
Price
$16.79
GF Value